Table 1

Ad5-induced gene expression in a liver of C57BL/6_WT mice (fold over Mock, 6 hours after injection)

MockAd5-GFPAd5-IX-dGFPAd5-GFP-IX-dDAF4Ad5-GFP-IX-dDAF4_REO
ADAR* 1.0 ± 0.3 2.2 ± 0.4 2.6 ± 0.2 1.9 ± 0.5 2.4 ± 0.8 
CD14* 1.0 ± 0.2 6.0 ± 1.5 10.0 ± 5.4 6.2 ± 3.2 3.4 ± 2.4 
CXCL-9 1.0 ± 0.2 10.7 ± 3.0 17.4 ± 5.7 10.6 ± 1.2 5.1 ± 1.3§ 
DAF 1.0 ± 0.1 1.5 ± 0.5 1.2 ± 0.2 1.5 ± 0.3 1.1 ± 0.2 
e-Selectin 1.0 ± 0.4 4.0 ± 0.6 5.7 ± 1.0 3.7 ± 1.3 3.5 ± 0.8 
ICAM* 1.0 ± 0.3 4.2 ± 0.4 3.8 ± 0.8 3.6 ± 0.7 2.2 ± 0.3§ 
IFNα 1.0 ± 0.4 1.3 ± 0.4 1.4 ± 0.1 0.8 ± 0.5 1.5 ± 0.5 
IFNβ 1.0 ± 0.4 1.2 ± 0.4 1.5 ± 0.3 0.8 ± 0.5 1.7 ± 0.7 
IRF-7 1.0 ± 0.4 16.4 ± 3.6 19.6 ± 2.7 16.5 ± 5.0 10.9 ± 2.2§ 
IRF-8 1.0 ± 0.2 3.7 ± 1.1 3.6 ± 0.8 3.2 ± 1.1 1.9 ± 0.4§ 
Jak-1 1.0 ± 0.3 2.3 ± 0.6 1.6 ± 0.3 1.8 ± 0.6 1.3 ± 0.3§ 
Jak-3 1.0 ± 0.2 2.8 ± 0.8 1.7 ± 0.2 1.9 ± 1.0 1.2 ± 0.4§ 
MyD88* 1.0 ± 0.3 7.0 ± 1.4 8.9 ± 1.3 6.9 ± 1.9 4.0 ± 0.9§ 
NFκB-RelA 1.0 ± 0.2 2.1 ± 0.4 2.6 ± 0.6 1.7 ± 0.4 1.2 ± 0.2§ 
NOD-1 1.0 ± 0.2 2.4 ± 0.4 2.6 ± 0.3 2.7 ± 0.5 1.9 ± 0.3 
NOD-2 1.0 ± 0.4 2.0 ± 0.4 2.3 ± 0.2 1.5 ± 0.4 2.4 ± 0.7 
OAS-1a* 1.0 ± 0.5 12.1 ± 1.0 14.5 ± 1.4 12.9 ± 4.8 5.9 ± 1.6§ 
SOCS-1* 1.1 ± 0.7 12.6 ± 4.0 12.7 ± 4.1 11.7 ± 4.7 6.7 ± 2.3 
SOCS-3* 1.1 ± 0.6 5.4 ± 1.8 5.8 ± 1.4 4.6 ± 0.9 4.0 ± 0.9 
TBK-1 1.0 ± 0.2 6.5 ± 0.8 6.1 ± 1.7 6.7 ± 1.9 3.5 ± 0.7§ 
TLR-2* 1.0 ± 0.4 45.2 ± 14.3 86.7 ± 30.0 48.4 ± 16.0 29.3 ± 7.6 
TLR-3* 1.0 ± 0.2 19.2 ± 2.9 29.7 ± 4.0 25.3 ± 7.0 15.0 ± 6.0 
TLR-6* 1.0 ± 0.3 6.0 ± 1.6 4.2 ± 0.6 6.0 ± 2.6 3.0 ± 0.9§ 
TLR-9* 1.0 ± 0.2 2.0 ± 0.4 2.5 ± 0.3 1.9 ± 0.4 2.5 ± 0.8 
TRAF2bp* 1.1 ± 0.5 16.3 ± 7.8 36.2 ± 6.3 19.7 ± 6.3 8.2 ± 1.9§ 
VCAM 1.0 ± 0.4 2.1 ± 0.8 1.9 ± 0.1 1.5 ± 0.7 1.7 ± 0.6 
MockAd5-GFPAd5-IX-dGFPAd5-GFP-IX-dDAF4Ad5-GFP-IX-dDAF4_REO
ADAR* 1.0 ± 0.3 2.2 ± 0.4 2.6 ± 0.2 1.9 ± 0.5 2.4 ± 0.8 
CD14* 1.0 ± 0.2 6.0 ± 1.5 10.0 ± 5.4 6.2 ± 3.2 3.4 ± 2.4 
CXCL-9 1.0 ± 0.2 10.7 ± 3.0 17.4 ± 5.7 10.6 ± 1.2 5.1 ± 1.3§ 
DAF 1.0 ± 0.1 1.5 ± 0.5 1.2 ± 0.2 1.5 ± 0.3 1.1 ± 0.2 
e-Selectin 1.0 ± 0.4 4.0 ± 0.6 5.7 ± 1.0 3.7 ± 1.3 3.5 ± 0.8 
ICAM* 1.0 ± 0.3 4.2 ± 0.4 3.8 ± 0.8 3.6 ± 0.7 2.2 ± 0.3§ 
IFNα 1.0 ± 0.4 1.3 ± 0.4 1.4 ± 0.1 0.8 ± 0.5 1.5 ± 0.5 
IFNβ 1.0 ± 0.4 1.2 ± 0.4 1.5 ± 0.3 0.8 ± 0.5 1.7 ± 0.7 
IRF-7 1.0 ± 0.4 16.4 ± 3.6 19.6 ± 2.7 16.5 ± 5.0 10.9 ± 2.2§ 
IRF-8 1.0 ± 0.2 3.7 ± 1.1 3.6 ± 0.8 3.2 ± 1.1 1.9 ± 0.4§ 
Jak-1 1.0 ± 0.3 2.3 ± 0.6 1.6 ± 0.3 1.8 ± 0.6 1.3 ± 0.3§ 
Jak-3 1.0 ± 0.2 2.8 ± 0.8 1.7 ± 0.2 1.9 ± 1.0 1.2 ± 0.4§ 
MyD88* 1.0 ± 0.3 7.0 ± 1.4 8.9 ± 1.3 6.9 ± 1.9 4.0 ± 0.9§ 
NFκB-RelA 1.0 ± 0.2 2.1 ± 0.4 2.6 ± 0.6 1.7 ± 0.4 1.2 ± 0.2§ 
NOD-1 1.0 ± 0.2 2.4 ± 0.4 2.6 ± 0.3 2.7 ± 0.5 1.9 ± 0.3 
NOD-2 1.0 ± 0.4 2.0 ± 0.4 2.3 ± 0.2 1.5 ± 0.4 2.4 ± 0.7 
OAS-1a* 1.0 ± 0.5 12.1 ± 1.0 14.5 ± 1.4 12.9 ± 4.8 5.9 ± 1.6§ 
SOCS-1* 1.1 ± 0.7 12.6 ± 4.0 12.7 ± 4.1 11.7 ± 4.7 6.7 ± 2.3 
SOCS-3* 1.1 ± 0.6 5.4 ± 1.8 5.8 ± 1.4 4.6 ± 0.9 4.0 ± 0.9 
TBK-1 1.0 ± 0.2 6.5 ± 0.8 6.1 ± 1.7 6.7 ± 1.9 3.5 ± 0.7§ 
TLR-2* 1.0 ± 0.4 45.2 ± 14.3 86.7 ± 30.0 48.4 ± 16.0 29.3 ± 7.6 
TLR-3* 1.0 ± 0.2 19.2 ± 2.9 29.7 ± 4.0 25.3 ± 7.0 15.0 ± 6.0 
TLR-6* 1.0 ± 0.3 6.0 ± 1.6 4.2 ± 0.6 6.0 ± 2.6 3.0 ± 0.9§ 
TLR-9* 1.0 ± 0.2 2.0 ± 0.4 2.5 ± 0.3 1.9 ± 0.4 2.5 ± 0.8 
TRAF2bp* 1.1 ± 0.5 16.3 ± 7.8 36.2 ± 6.3 19.7 ± 6.3 8.2 ± 1.9§ 
VCAM 1.0 ± 0.4 2.1 ± 0.8 1.9 ± 0.1 1.5 ± 0.7 1.7 ± 0.6 

Medium dose of virus used for injection was 0.75 × 1011 vp/mouse. The numbers represent mean ± SD. Statistical analysis was completed using one-way analysis of variance with a Student-Newman-Keuls post hoc test; P < .05 was deemed a statistically significant difference. n = 4 for mock-injected groups, n = 5 for virus-injected groups.

*

Genes shown to be induced in C3-dependent manner after systemic Ad injection [2].

Significant differences compared to WT_Mock.

Significant induction of transcriptional activation compared to WT_Ad5-GFP group.

§

Significant reductions of transcriptional activation compared to WT_Ad5-GFP group.

Close Modal

or Create an Account

Close Modal
Close Modal